Background
Materials and methods
Study population
Diagnostic criteria of bacterial brain abscess
Diagnostic criteria and therapeutic regimens of nasopharyngeal carcinoma (NPC)
Exclusion and inclusion criteria
Clinical assessment
Therapeutic regimens
Outcome assessment
Statistical analysis
Results
Baseline data of study patients
Non-NPC patients
|
NPC patients
|
p value
|
OR
|
95% CI
| |
---|---|---|---|---|---|
n = 198 (%)
|
n = 12 (%)
| ||||
Mean age, years
|
45.8±18.2
|
48.3±12.7
| |||
Sex (male/female)
|
147/51
|
9/3
|
1.0
|
1.041
|
0.27-3.99
|
Median (IQR) GCS on presentation
|
15 (14, 15)
|
13.5 (10.3, 15.0)
|
0.39
| ||
Underlying diseases
| |||||
Congenital heart diseases
|
2 (0.1)
|
0
|
1.0
|
0.942
|
0.911-0.975
|
Diabetes mellitus
|
42 (21.2)
|
1 (8.3)
|
0.466
|
0.34
|
0.042-2.69
|
Alcoholism/liver cirrhosis
|
9 (4.5)
|
0
|
1.0
|
0.94
|
0.91-0.97
|
Chronic otitis media
|
20 (10.1)
|
8 (66.6)
|
<0.0001
|
17.8
|
4.9-64.4
|
Postneurosurgical state
|
43 (21.7)
|
5 (41.6)
|
0.151
|
2.58
|
0.778-8.52
|
Neuroimaging findings at presentation
| |||||
Multiple/ Solitary
| |||||
Multiloculated
|
41 (20.7)
|
3 (25)
|
0.718
|
1.276
|
0.331-4.929
|
Involved temporal lobe
|
65 (32.8)
|
8 (66.6)
|
0.026
|
4.092
|
1.19-14.1
|
Hydrocephalus
|
32 (16.2)
|
3 (25)
|
0.426
|
1.729
|
0.444-6.74
|
Post-radiation necrosis
|
0 (0)
|
3 (25)
|
<0.001
|
0.044
|
0.023-0.083
|
Clinical features following brain abscess
| |||||
Fever/chills
|
119 (60.1)
|
10 (83.3)
|
0.135
|
3.319
|
0.708-15.55
|
Headache
|
108 (54.5)
|
9 (75)
|
0.234
|
2.5
|
0.657-9.512
|
Disturbed consciousness
|
87 (43.9)
|
5 (41.6)
|
0.878
|
0.911
|
0.28-2.97
|
Septic shock
|
30 (15.1)
|
1(8.3)
|
1.0
|
0.509
|
0.063-4.09
|
Sensory disturbance
|
29 (14.6)
|
0
|
0.379
|
0.934
|
0.898-0.971
|
Hemiparesis
|
95 (47.9)
|
4 (33.3)
|
0.324
|
0.542
|
0.158-1.859
|
Visual disturbance
|
27 (13.6)
|
1 (8.3)
|
1.0
|
0.576
|
0.071-4.641
|
Neck Stiff neck
|
59 (29.8)
|
5 (41.6)
|
0.519
|
1.683
|
0.513-5.517
|
Facial palsy
|
12 (6)
|
1 (8.3)
|
0.545
|
1.409
|
0.168-11.842
|
Seizure
|
50 (25.2)
|
0
|
0.074
|
0.925
|
0.885-0.967
|
Speech disturbance
|
8 (4)
|
0
|
1.0
|
0.941
|
0.909-0.974
|
concomitant bacterial meningitis
|
74 (37.4)
|
4 (33.3)
|
1.0
|
0.838
|
0.244-2.879
|
Treatment
| |||||
Combination of Surgical and antimicrobial therapy
|
162 (81.8)
|
10 (83.3)
|
1.0
|
1.11
|
0.23-5.29
|
Antimicrobial treatment only
|
36 (18.2)
|
2 (16.6)
| |||
Outcome
| |||||
Death
|
41 (20.7)
|
2 (16.7)
|
1.0
|
0.766
|
1.61-3.63
|
Median (IRQ) hospitalization days
|
44 (28–66.5)
|
35 (25.5- 56.8)
|
0.501
| ||
Median (IQR) GOS at discharge
|
4 (2–5)
|
4 (1.3 5.0)
|
0.544
| ||
Median (IQR) GOS at a minimum of 18 month follow-up
|
5 (5–5)
|
5 (4.3- 5.0)
|
0.385
|
Causative pathogens and neuro-imaging findings
Non-NPC patients
|
NPC patients
| |
---|---|---|
n = 198 (%)
|
n = 12 (%)
| |
Gram-negative bacilli (n = 50)
|
49 (24.7)
|
1
α
(8.3)
|
Streptococcus species (n = 43)
| ||
Viridans streptococci
|
31 (15.7)
|
4 (33.3)
|
Other Streptococci
|
8 (4.0)
|
0
|
Anaerobic pathogens (n = 38 )
|
37 (18.7)
|
1
β
(8.3)
|
Staphylococcus species (n = 21)
| ||
Staphylococcus aureus
|
9 (4.5)
|
2 (16.7)
|
Other Staphylococcus species
|
10 (5.1)
|
0
|
Mixed bacterial pathogens (n = 19)
|
18 (9.1)
|
1
γ
(8.3)
|
Negative culture (n = 39)
|
36 (18.2)
|
3 (25)
|
Non-NPC patients
|
NPC patients
| |
---|---|---|
n = 198 (%)
|
n = 12 (%)
| |
Location
| ||
Single site
| ||
Frontal lobe
|
15 (7.5)
|
0
|
Fronto-parietal area
|
23 (11.6)
|
1 (8.3)
|
Fronto-parito-temporal area
|
17 (8.6)
|
1 (8.3)
|
Basal ganglion
|
12 (6.1)
|
0
|
Temporal lobe
|
17 (8.6)
|
6 (50)
|
Parieto-occipital area
|
22 (11.1)
|
1 (8.3)
|
Parietal lobe
|
15 (7.6)
|
0
|
Temporo-parietal area
|
16 (8.0)
|
0
|
Thalamus
|
4 (2.0)
|
0
|
Occipital lobe
|
3 (1.5)
|
0
|
Cerebellum
|
9 (4.5)
|
1 (8.3)
|
Multiple sites
|
45 (22.7)
|
2
δ
(16.6)
|
Multiloculated
|
41 (20.7)
|
3 (25)
|
Rupture into ventricle
|
62 (31.3)
|
5 (41.7)
|
Hydrocephalus
|
32 (16.2)
|
3 (25)
|
Median (IRQ) volumes of brain abscess (cm
3
)
β
|
13.19 (4.03-25.13)
|
17.49 (7.47-28.162)
|